BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37309281)

  • 1. Variations in pleural microbiota and metabolic phenotype associated with malignant pleural effusion in human lung adenocarcinoma.
    Huang D; Zhuo J; Ye C; Su X; Chen Y; Li C; Lin L; Liu L; Zhao H; Luo T; Ren Q; Wu J; Cai S; Dong H
    Thorac Cancer; 2023 Jul; 14(21):2045-2056. PubMed ID: 37309281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancer.
    Yang Z; Song Z; Chen Z; Guo Z; Jin H; Ding C; Hong Y; Cai Z
    J Pharm Biomed Anal; 2020 Feb; 180():113069. PubMed ID: 31884394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomics revealed protein biomarkers to distinguish malignant pleural effusion from benign pleural effusion.
    Dong T; Liang Y; Chen H; Li Y; Li Z; Gao X
    J Proteomics; 2024 Jun; 302():105201. PubMed ID: 38768894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleural fluid microbiota as a biomarker for malignancy and prognosis.
    Kwok B; Wu BG; Kocak IF; Sulaiman I; Schluger R; Li Y; Anwer R; Goparaju C; Ryan DJ; Sagatelian M; Dreier MS; Murthy V; Rafeq S; Michaud GC; Sterman DH; Bessich JL; Pass HI; Segal LN; Tsay JJ
    Sci Rep; 2023 Feb; 13(1):2229. PubMed ID: 36755121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiome profile associated with malignant pleural effusion.
    Shojaee S; Sharma A; Gottel N; Sanchez T; Gilbert JA; Rahman NM
    PLoS One; 2020; 15(5):e0232181. PubMed ID: 32384089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal MicroRNA Expression Profiling in Patients with Lung Adenocarcinoma-associated Malignant Pleural Effusion.
    Tamiya H; Mitani A; Saito A; Ishimori T; Saito M; Isago H; Jo T; Yamauchi Y; Tanaka G; Nagase T
    Anticancer Res; 2018 Dec; 38(12):6707-6714. PubMed ID: 30504380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Methylation of
    Zhong Q; Wang Y; Liang C; Wei F; She B
    Discov Med; 2023 Oct; 35(178):845-852. PubMed ID: 37811622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Platelet Parameters in the Differential Diagnosis of Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Tuberculous Pleural Effusion.
    Ai L; Li J; Ye T; Wang W; Li Y
    Dis Markers; 2022; 2022():5653033. PubMed ID: 35531478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in
    Xie T; Wang Q; Gao J; He K; Yu J
    Ann Clin Lab Sci; 2024 Mar; 54(2):201-210. PubMed ID: 38802158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of pleural interleukin 17 and carcinoembryonic antigen in lung cancer patients with malignant pleural effusions.
    Xu CH; Zhan P; Yu LK; Zhang XW
    Tumour Biol; 2014 Feb; 35(2):1599-603. PubMed ID: 24072496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with adenocarcinoma of the lung.
    Wang S; Chen H; Zhong J; Qin H; Bai H; Zhao J; Wang J
    Lung Cancer; 2019 Sep; 135():116-122. PubMed ID: 31446983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray expression profile and analysis of circular RNA regulatory network in malignant pleural effusion.
    Wen Y; Wang Y; Xing Z; Liu Z; Hou Z
    Cell Cycle; 2018; 17(24):2819-2832. PubMed ID: 30563416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
    Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
    Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
    Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
    Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell transcriptomics reveal metastatic CLDN4+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non-small-cell lung cancer.
    Zhang X; Wang X; Wen Y; Chen S; Zhou C; Wu F
    Clin Transl Med; 2024 Apr; 14(4):e1649. PubMed ID: 38629624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in malignant pleural effusion in patients with lung cancer.
    Xu CH; Hao KK; Yu LK; Zhang XW
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):28-33. PubMed ID: 24720371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.
    Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
    Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma-induced malignant pleural effusion.
    Tao H; Meng Q; Li M; Shi L; Tang J; Liu Z
    Thorac Cancer; 2018 Feb; 9(2):298-304. PubMed ID: 29297985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.
    Tian T; Li J; Hu W; Sun C; Zhou J
    J Clin Lab Anal; 2019 Jul; 33(6):e22901. PubMed ID: 30985967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of pleural effusion Krebs von den Lungen-6 in malignant pleural effusion of patients with non-small cell lung cancer.
    Wang J; Ling L; Chen S; Chou L; Wang Y; Hu L
    Lab Med; 2024 May; 55(3):271-276. PubMed ID: 37566516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.